Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKrystal Biotech Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | $1.34 | $1.65 | $1.49 |
| Q2 2026 | 6 | $1.56 | $1.94 | $1.77 |
| Q3 2026 | 6 | $1.62 | $2.30 | $1.97 |
| Q4 2026 | 4 | $2.03 | $2.29 | $2.14 |
| Q1 2027 | 2 | $2.58 | $2.90 | $2.72 |
| Q2 2027 | 2 | $2.36 | $2.66 | $2.49 |
| Q3 2027 | 2 | $2.81 | $3.16 | $2.96 |
| Q4 2027 | 2 | $3.46 | $3.90 | $3.65 |
Krystal Biotech Inc Earnings Date And Information
Krystal Biotech Inc last posted its earnings results on Monday, May 4th, 2026. The company reported $1.83 earnings per share for the quarter, topping analysts' consensus estimates of $1.45 by $0.38. The company had revenue of 116.36 M for the quarter and had revenue of 389.13 M for the year. Krystal Biotech Inc has generated $7 earnings per share over the last year ($6.84 diluted earnings per share) and currently has a price-to-earnings ratio of 44.31. Krystal Biotech Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Krystal Biotech Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/04/2026 | Q1 2026 | $1.45 | $1.91 | 0.46 | $112.11 M | $116.36 M |
| 02/17/2026 | Q4 2025 | $1.62 | $1.77 | 0.15 | $105.35 M | $107.11 M |
| 11/03/2025 | Q3 2025 | $1.12 | $2.74 | 1.62 | $93.19 M | $97.80 M |
| 08/04/2025 | Q2 2025 | $1.08 | $1.33 | 0.25 | $91.97 M | $96.04 M |
| 05/06/2025 | Q1 2025 | $1.38 | $1.24 | -0.14 | $96.21 M | $88.18 M |
| 02/19/2025 | Q4 2024 | $1.29 | $1.58 | 0.29 | $90.64 M | $91.14 M |
| 11/04/2024 | Q3 2024 | $0.90 | $0.95 | 0.05 | $82.94 M | $83.84 M |
| 08/05/2024 | Q2 2024 | $0.50 | $0.54 | 0.04 | $65.27 M | $70.28 M |
| 05/06/2024 | Q1 2024 | $0.15 | $0.03 | -0.12 | $47.37 M | $45.25 M |
| 02/26/2024 | Q4 2023 | -$0.38 | $0.31 | 0.69 | N/A | $42.14 M |
| 11/06/2023 | Q3 2023 | -$1.10 | $2.88 | 3.98 | N/A | $8.56 M |
| 08/07/2023 | Q2 2023 | -$0.42 | -$1.25 | -0.83 | N/A | $0 |
| 05/08/2023 | Q1 2023 | -$1.41 | -$1.76 | -0.35 | N/A | $0 |
| 02/27/2023 | Q4 2022 | -$1.39 | -$1.25 | 0.14 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$1.23 | -$1.17 | 0.06 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$1.08 | -$1.10 | -0.02 | N/A | $0 |
| 05/09/2022 | Q1 2022 | -$0.96 | -$1.99 | -1.03 | N/A | $0 |
| 02/28/2022 | Q4 2021 | -$0.76 | -$0.98 | -0.22 | N/A | $0 |
| 11/08/2021 | Q3 2021 | -$0.75 | -$0.70 | 0.05 | N/A | $0 |
| 08/09/2021 | Q2 2021 | -$0.74 | -$0.74 | 0 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Krystal Biotech Inc Earnings: FAQ's
In the previous quarter, Krystal Biotech Inc (:KRYS) reported $1.83 earnings per share (EPS) to beat the analysts' consensus estimate of $1.45 by $0.38.
The conference call for Krystal Biotech Inc's latest earnings report can be listened to online.
The conference call transcript for Krystal Biotech Inc's latest earnings report can be read online.
Krystal Biotech Inc (:KRYS) has a recorded annual revenue of $389.13 M.
Krystal Biotech Inc (:KRYS) has a recorded net income of $204.83 M.Krystal Biotech Inc has generated $7.08 earnings per share over the last four quarters.
Krystal Biotech Inc (:KRYS) has a price-to-earnings ratio of 44.31 and price/earnings-to-growth ratio is 0.56.